Dermatology News

• EADV 2023 Novel Subcutaneous Biologics Show Promise in AD Patients with moderate to severe atopic dermatitis could soon have more therapeutic options, with monoclonal antibodies targeting novel immune pathways that reduce disease severity, suggest two trials.
  Medscape Medical News, December 01, 2023
• Meta-Analysis: Suicide Risk Not Increased With Isotretinoin In fact, those treated with the drug for severe acne may have a lower risk for suicide attempts 2-4 years after treatment, according to the study authors.
  MDedge News, December 01, 2023
• Dietary Supplements May Play a Role in Managing Vitiligo Dietary supplements have a role in the integrative treatment of vitiligo, largely through antioxidant pathways and as an adjuvant to phototherapy.
  MDedge News, November 30, 2023
• Pilonidal Disease: Study Finds Laser Hair Removal Beneficial The study compared laser epilation plus standard of care with standard care alone for patients aged 11-20 years with pilonidal disease.
  MDedge News, November 30, 2023
• Tapinarof Effective for AD in Patients as Young as 2 years Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults.
  MDedge News, November 28, 2023
• Nail Psoriasis in Black Patients Often Overlooked Underrepresentation of Black patients with psoriasis in trials and textbooks might partially explain why clinicians are slow to recognize nail involvement, even after psoriasis has been diagnosed.
  MDedge News, November 28, 2023
• Alert FDA Warns of Potentially Lethal Reaction to Seizure Meds Levetiracetam and clobazam can cause a rare but serious drug reaction with eosinophilia and systemic symptoms that can be life threatening if not diagnosed and treated quickly, the FDA warns.
  Medscape Medical News, November 28, 2023
• HS: Positive Results Reported With Anti-IL17A/F Therapies One of the trials evaluated a nanobody inhibitor, sonelokimab, a molecule with a substantially smaller size than traditional monoclonal antibodies.
  MDedge News, November 28, 2023
• EADV 2023 At 52 Weeks, Hair Growth Still Climbing on Deuruxolitinib With response curves still climbing at follow-up to date, the results are 'truly, truly remarkable.'
  MDedge News, November 28, 2023
• Methotrexate Carries Higher Risk for Older CKD Patients Adverse event data showed an increased risk of myelosuppression, sepsis, pneumotoxic effects, or hepatotoxic effects.
  Medscape Medical News, November 27, 2023
• Parent Concerns a Factor When Treating Patients With AD For a parent whose child has an inflammatory skin disease, pigmentation changes, rather than inflammation, might be the reason that he or she brought the child to the clinician.
  MDedge News, November 23, 2023
• Questionnaire Measures Patient Satisfaction With Acne Tx A dermatology-specific questionnaire assessed three aspects of treatment in patients with acne.
  Medscape Medical News, November 22, 2023
• Risks Quantified in Medically Optimized Pregnancy With Lupus Patients who were not medically optimized for pregnancy were three times more likely to experience preterm birth and preeclampsia.
  Medscape Medical News, November 21, 2023
• Choosing the Right Approach to Cancer and Menopause Symptoms Hormone replacement therapy may be considered to lessen these symptoms, but only in certain conditions, said a gynecologist.
  Medscape Medical News, November 21, 2023
• Circadian Calorie-Burning Cycles Altered in Obesity Among people with obesity, the lowest point of energy expenditure is not during sleeping hours, as seen in those without obesity.
  Medscape Medical News, November 21, 2023
• ACR 2023 IV Secukinumab Trials Hit Primary Endpoints in PsA, AxSpA Two phase 3 trials of the recently approved IV formulation of secukinumab showed its efficacy vs placebo in treating psoriatic arthritis and axial spondyloarthritis.
  MDedge News, November 20, 2023
• Lebrikizumab Gets the Nod in the EU for Atopic Dermatitis Lebrikizumab, an interleukin-13 inhibitor, is not yet approved in the United States.
  MDedge News, November 20, 2023
• Before Signing an Offer Letter: Read This You just received an offer letter, but should you sign it right away? How legally binding is it? Is it the same as a contract? Experts weigh in.
  Medscape Medical News, November 17, 2023
• New Consensus Guide on Rare Drug Hypersensitivity Reaction Experts provided parameters to help clinicians, but they acknowledged the limited evidence base for drug reaction with eosinophilia and systemic symptoms.
  Medscape Medical News, November 17, 2023
• Amazon Says Unapproved Eye Drops Being Removed From Website Amazon said on Wednesday it was in the process of removing seven unapproved eye drops from its e-commerce platform following a warning letter from the U.S. health regulator earlier this week.
  Reuters Health Information, November 15, 2023
• FDA Warns Amazon Against Sale of Unapproved Eye Drops The US Food and Drug Administration said on Tuesday it had sent a warning letter to Amazon.com related to sale of seven unapproved eye drops on the company's e-commerce platform.
  Reuters Health Information, November 14, 2023
• Should Physicians Go to Work When Sick? Although most doctors believe it's best to stay home if they're ill, today's healthcare system makes the answer much more complicated.
  Medscape Medical News, November 13, 2023
• Neoadj T-VEC May Improve Survival in Resectable Melanoma Offering talimogene laherparepvec before surgery compared with surgery alone could improve event-free as well as overall survival in patients with advanced resectable melanoma, a new analysis suggests.
  Medscape Medical News, August 22, 2023